Phase Ib trial combining capecitabine, erlotinib and bevacizumab in pancreatic adenocarcinoma

Phase Ib trial combining capecitabine, erlotinib and bevacizumab in pancreatic adenocarcinoma - REBECA trial

Published:2018-07-12 Issue:1 Volume:37 Page:127-138
ISSN:0167-6997
Container-title:Investigational New Drugs
language:en
Short-container-title:Invest New Drugs

Author:

Dittrich Christian,Königsberg Robert,Mittlböck Martina,Geissler Klaus,Sahmanovic-Hrgovcic Azra,Pleiner-Duxneuner Johannes,Czejka Martin,Buchner Philipp

Funder

Österreichische Forschungsförderungsgesellschaft

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s10637-018-0639-0.pdf

Reference57 articles.

1. Dreyer SB, Chang DK, Bailey P, Biankin AV (2017) Pancreatic cancer genomes: implications for clinical management and therapeutic development. Clin Cancer Res 23:1638–1646. https://doi.org/10.1158/1078-0432.CCR-16-2069

2. Burris HA 3rd, Moore MJ, Andersen J, Green MR, Rothenberg ML, Modiano MR, Cripps MC, Portenoy RK, Storniolo AM, Tarassoff P, Nelson R, Dorr FA, Stephens CD, Von Hoff DD (1997) Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. J Clin Oncol 15:2403–2413

3. Conroy T, Desseigne F, Ychou M, Bouché O, Guimbaud R, Bécouarn Y, Adenis A, Raoul JL, Gourgou-Bourgade S, de la Fouchardière C, Bennouna J, Bachet JB, Khemissa-Akouz F, Péré-Vergé D, Delbaldo C, Assenat E, Chauffert B, Michel P, Montoto-Grillot C, Ducreux M, for the Groupe Tumeurs Digestives of Unicancer and PRODIGE Intergroup (2011) FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer. N Engl J Med 364:1817–1825. https://doi.org/10.1056/NEJMoa1011923

4. Von Hoff DD, Ervin T, Arena FP, Chiorean EG, Infante J, Moore M, Seay T, Tjulandin SA, Ma WW, Saleh MN, Harris M, Reni M, Dowden S, Laheru D, Bahary N, Ramanathan RK, Tabernero J, Hidalgo M, Goldstein D, Van Cutsem E, Wei X, Iglesias J, Renschler MF (2013) Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine. N Engl J Med 369:1691–1703. https://doi.org/10.1056/NEJMoa1304369

5. Welch SA, Moore MJ (2007) Combination chemotherapy in advanced pancreatic cancer: time to raise the white flag? J Clin Oncol 25:2159–2161